{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T06:47:39Z","timestamp":1765608459308},"reference-count":31,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Sex Transm Infect"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1136\/sextrans-2014-051537","type":"journal-article","created":{"date-parts":[[2014,6,4]],"date-time":"2014-06-04T22:20:15Z","timestamp":1401920415000},"page":"363-369","update-policy":"http:\/\/dx.doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":25,"title":["HPTN 035 phase II\/IIb randomised safety and effectiveness study of the vaginal microbicides BufferGel and 0.5% PRO 2000 for the prevention of sexually transmitted infections in women"],"prefix":"10.1136","volume":"90","author":[{"given":"M Bradford","family":"Guffey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbra","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marla","family":"Husnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonus","family":"Makanani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Chilongozi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elmer","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gita","family":"Ramjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nyaradzo","family":"Mgodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kailazarid","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon L","family":"Hillier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim Abdool","family":"Karim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the HIV Prevention Trials Network (HPTN) 035 Study Team","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2014,6,4]]},"reference":[{"volume-title":"Global strategy for the prevention and control of sexually transmitted infections: 2006\u20132015","year":"2007","author":"World Health Organization","key":"key-10.1136\/sextrans-2014-051537-1"},{"key":"key-10.1136\/sextrans-2014-051537-2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/00007435-200205000-00009","article-title":"Using sexually transmitted disease incidence as a surrogate marker for HIV incidence in prevention trials: a modeling study","volume":"29","author":"Pinkerton","year":"2002","journal-title":"Sex Transm Dis"},{"key":"key-10.1136\/sextrans-2014-051537-3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/sti.75.1.3","article-title":"From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection","volume":"75","author":"Fleming","year":"1999","journal-title":"Sex Transm Infect"},{"key":"key-10.1136\/sextrans-2014-051537-4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/infdis\/163.2.233","article-title":"Cofactors in male-female sexual transmission of human immunodeficiency virus type 1","volume":"163","author":"Plummer","year":"1991","journal-title":"J Infect Dis"},{"key":"key-10.1136\/sextrans-2014-051537-5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00002030-199301000-00015","article-title":"Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study","volume":"7","author":"Laga","year":"1993","journal-title":"AIDS"},{"key":"key-10.1136\/sextrans-2014-051537-6","unstructured":"UNAIDS. Joint United Nations Programme on HIV\/AIDS. 2008 Report on the global AIDS Epidemic. http:\/\/data.unaids.org\/pub\/GlobalReport\/2008\/"},{"key":"key-10.1136\/sextrans-2014-051537-7","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1086\/522610","article-title":"Preventing the sexual transmission of HIV-1 with topical microbicides: another piece of the equation","volume":"196","author":"Rohan","year":"2007","journal-title":"J Infect Dis"},{"key":"key-10.1136\/sextrans-2014-051537-8","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/QAI.0b013e31817aebd6","article-title":"Using modeling to explore the degree to which a microbicide's sexually transmitted infection efficacy may contribute to the HIV effectiveness measured in phase 3 microbicide trials","volume":"48","author":"Vickerman","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.1136\/sextrans-2014-051537-9","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(10)61086-0","article-title":"PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial","volume":"376","author":"McCormack","year":"2010","journal-title":"Lancet"},{"key":"key-10.1136\/sextrans-2014-051537-10","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/QAD.0b013e32834541d9","article-title":"Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women","volume":"25","author":"Abdool Karim","year":"2011","journal-title":"AIDS"},{"key":"key-10.1136\/sextrans-2014-051537-11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0010-7824(99)00102-X","article-title":"Study of the vaginal tolerance to Acidform, an acid-buffering, bioadhesive gel","volume":"60","author":"Amaral","year":"1999","journal-title":"Contraception"},{"issue":"(4 Pt 1)","key":"key-10.1136\/sextrans-2014-051537-12","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/0002-9378(95)91491-9","article-title":"Antichlamydial activity of vaginal secretion","volume":"172","author":"Mahmoud","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.1136\/sextrans-2014-051537-13","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/381125","article-title":"Inhibition of Neisseria gonorrhoeae genital tract infection by leading-candidate topical microbicides in a mouse model","volume":"189","author":"Spencer","year":"2004","journal-title":"J Infect Dis"},{"key":"key-10.1136\/sextrans-2014-051537-14","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/00007435-200211000-00007","article-title":"Microbicide efficacy and toxicity tests in a mouse model for vaginal transmission of Chlamydia trachomatis","volume":"29","author":"Achilles","year":"2002","journal-title":"Sex Transm Dis"},{"key":"key-10.1136\/sextrans-2014-051537-15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00007435-200107000-00010","article-title":"Tests of Buffergel for contraception and prevention of sexually transmitted diseases in animal models","volume":"28","author":"Zeitlin","year":"2001","journal-title":"Sex Transm Dis"},{"key":"key-10.1136\/sextrans-2014-051537-16","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/01.OLQ.0000124614.91448.D4","article-title":"Safety and efficacy evaluations for vaginal and rectal use of BufferGel in the macaque model","volume":"31","author":"Patton","year":"2004","journal-title":"Sex Transm Dis"},{"key":"key-10.1136\/sextrans-2014-051537-17","unstructured":"Profy AT, Sonderfan AJ, Chancellor T, et al. PRO 2000: a candidate topical microbicide based on naphthalene sulfonate polymer with antimicrobial and contraceptive properties. Abstract B20; Microbicides 2000; Washinton, DC, 2000."},{"article-title":"PRO 2000 gel, a potential topical microbicide for HIV prevention, can block infection by other sexually transmitted disease pathogens. Abstract Number 33146; International Conference on AIDS","year":"1998","author":"Profy","key":"key-10.1136\/sextrans-2014-051537-18"},{"volume-title":"Guidelines for the management of sexually transmitted infections","author":"World Health Organization","key":"key-10.1136\/sextrans-2014-051537-19"},{"key":"key-10.1136\/sextrans-2014-051537-20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1128\/JCM.01656-08","article-title":"Stepwise diagnosis of Trichomonas vaginalis infection in adolescent women","volume":"47","author":"Pattullo","year":"2009","journal-title":"J Clin Microbiol"},{"key":"key-10.1136\/sextrans-2014-051537-21","doi-asserted-by":"crossref","first-page":"914","DOI":"10.7326\/0003-4819-142-11-200506070-00010","article-title":"Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae","volume":"142","author":"Cook","year":"2005","journal-title":"Ann Intern Med"},{"key":"key-10.1136\/sextrans-2014-051537-22","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1086\/422603","article-title":"Some design issues in trials of microbicides for the prevention of HIV infection","volume":"190","author":"Fleming","year":"2004","journal-title":"J Infect Dis"},{"key":"key-10.1136\/sextrans-2014-051537-23","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/QAI.0b013e31828607c5","article-title":"Appropriateness of hydroxyethylcellulose gel as a placebo control in vaginal microbicide trials: a comparison of the two control arms of HPTN 035","volume":"63","author":"Richardson","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.1136\/sextrans-2014-051537-24","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/sim.4780131709","article-title":"Standardized rates of recurrent outcomes","volume":"13","author":"Stukel","year":"1994","journal-title":"Stat Med"},{"key":"key-10.1136\/sextrans-2014-051537-25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/OLQ.0b013e318191ba01","article-title":"Risk factors for incidence of sexually transmitted infections among women in South Africa, Tanzania, and Zambia: results from HPTN 055 study","volume":"36","author":"Kapiga","year":"2009","journal-title":"Sex Transm Dis"},{"key":"key-10.1136\/sextrans-2014-051537-26","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/QAI.0b013e31828607c5","article-title":"Appropriateness of hydroxyethylcellulose gel as a placebo control in vaginal microbicide trials: a comparison of the two control arms of HPTN 035","volume":"63","author":"Richardson","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.1136\/sextrans-2014-051537-27","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1136\/sti.2002.004101","article-title":"Approaches to the control of sexually transmitted infections in developing countries: old problems and modern challenges","volume":"80","author":"Mayaud","year":"2004","journal-title":"Sex Transm Infect"},{"article-title":"Pre-exposure prophylaxis for HIV in women: daily oral tenofovir, oral tenofovir\/emtricitabine or vaginal tenofovir gel in the VOICE study (MTN 003). Oral Abstract 26LB; 20th Conference on Retroviruses and Opportunistic Infections","year":"2013","author":"Marrazzo","key":"key-10.1136\/sextrans-2014-051537-28"},{"key":"key-10.1136\/sextrans-2014-051537-29","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/S0140-6736(08)61842-5","article-title":"Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Skoler-Karpoff","year":"2008","journal-title":"Lancet"},{"key":"key-10.1136\/sextrans-2014-051537-30","doi-asserted-by":"crossref","first-page":"e5340","DOI":"10.1371\/journal.pone.0005340","article-title":"Is Audio Computer-Assisted Self-Interview (ACASI) Useful in Risk Behaviour Assessment of Female and Male Sex Workers, Mombasa, Kenya?","volume":"4","author":"van der Elst","year":"2009","journal-title":"PLoS ONE"},{"key":"key-10.1136\/sextrans-2014-051537-31","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(05)67470-3","article-title":"Ciprofloxacin-resistant gonorrhoea in South Africa","volume":"366","author":"Moodley","year":"2005","journal-title":"Lancet"}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T04:54:35Z","timestamp":1601096075000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sextrans-2014-051537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,4]]},"references-count":31,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,7,15]]},"published-print":{"date-parts":[[2014,8]]}},"alternative-id":["10.1136\/sextrans-2014-051537"],"URL":"https:\/\/doi.org\/10.1136\/sextrans-2014-051537","relation":{},"ISSN":["1368-4973","1472-3263"],"issn-type":[{"type":"print","value":"1368-4973"},{"type":"electronic","value":"1472-3263"}],"subject":[],"published":{"date-parts":[[2014,6,4]]}}}